OpenAI Astra Cybersecurity Reveal: Skip Legacy Cybersecurity, Buy Zscaler

Zscaler (ZS) is reiterated as a “buy” on the view that its zero-trust platform is well positioned to offset accelerating AI-driven cyber threats, even as growth slows to ~25% YoY and the stock has underperformed. The article notes a recent earnings beat versus expectations, while forward guidance remains conservative at 16.6%-17.5% growth—though the analyst expects ZS to outperform those targets on improved execution and rising cybersecurity spend.

Analysis

The equity case is less about AI creating a brand-new demand wave and more about whether CISOs translate higher threat intensity into incremental budget rather than vendor substitution. In that framework, ZS is a beneficiary only if buyers keep favoring best-of-breed zero-trust architecture; otherwise incremental spend is likely to consolidate into broader platforms at PANW and CRWD, which can capture more wallet share and leave ZS with the lower-multiple “niche winner” label. The second-order risk is that AI also helps attackers scale faster than defenders, which increases urgency but can lengthen procurement cycles as customers demand tighter proof of ROI.

Near term, the market is likely to trade the next guide, not the last beat. A stable or slightly better-than-feared print can lift the stock for days, but the real re-rating requires evidence that remaining performance obligations, billings quality, or net retention are inflecting, not just that spending stays elevated. If growth stays in the high-teens/low-20s, multiple expansion may remain capped because investors will prefer names showing accelerating operating leverage rather than just defensive relevance.

The contrarian miss is that “AI security” is becoming a crowded narrative, so the marginal buyer may already be in the stock. What would invalidate the bull case is any sign that platform bundling from Microsoft/PANW continues to compress win rates, or that enterprise budgets shift from point solutions to fewer integrated purchases. Structural upside exists over 6-18 months if AI meaningfully expands the attack surface, but the path is likely choppy and dependent on a few earnings prints rather than a smooth secular rerating.

Key Decisions for Investors

• Own ZS only as a selective earnings-acceleration trade: buy on post-print weakness if management reaffirms at least mid-teens growth with improving billings quality; cut if forward growth falls below the current guide range or billings decelerate again.
• For relative value, consider a small long ZS / short IGV pair into the next report to isolate cybersecurity spend from broad software multiple risk; exit if IGV continues to outperform on AI platform enthusiasm.
• If you want convexity, use a 6-12 month call spread on ZS rather than outright shares; the bull case is a re-rating on evidence of AI-driven budget expansion, while downside is multiple compression if growth remains merely steady.
• Watch PANW and CRWD as the more likely beneficiaries of any security budget expansion; if they accelerate while ZS does not, the market is signaling that platform consolidation is winning over point-solution premium.